{"disease":{"id":"chronic-rhinosinusitis-with-nasal-polyps","name":"chronic rhinosinusitis with nasal polyps"},"drugs":{"marketed":[{"drug_id":"tezepelumab","indication_name":"Inadequately Controlled Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tezspire","generic_name":"TEZEPELUMAB","company_name":"AstraZeneca / Amgen","drug_phase":"marketed","molecular_target":"","drug_class":"Thymic Stromal Lymphopoietin Blocker [EPC]","quality_score":30,"revenue":null,"mechanism":null}],"pipeline":[{"drug_id":"rimegepant-75-mg","indication_name":"Acute treatment of chronic rhinosinusitis with and without nasal polyps","indication_type":"pipeline","phase":"Phase 3","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rimegepant 75 MG","generic_name":"rimegepant-75-mg","company_name":"Pfizer Inc.","drug_phase":"preclinical","molecular_target":"Calcitonin gene-related peptide (CGRP) receptor","drug_class":"CGRP receptor antagonist (gepant)","quality_score":25,"revenue":null,"mechanism":"Rimegepant selectively antagonizes the calcitonin gene-related peptide (CGRP) receptor to block migraine pain signaling."}],"offLabel":[],"totalMarketed":1,"totalPipeline":1},"trials":{"data":[{"nct_id":"NCT06231004","title":"Correlation Between the Microbiome and Type 2 Inflammatory Diseases of CRSwNP","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"The First Affiliated Hospital with Nanjing Medical University","has_results":false},{"nct_id":"NCT06970977","title":"CRS Questionnaire Validation Project","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"The European Forum for Research and Education in Allergy and Airway Diseases","has_results":false},{"nct_id":"NCT05529784","title":"Dupilumab in the Treatment of Severe Uncontrolled CRSwNP: a Multicentre Observational Real-life Study (DUPIREAL)","phase":"","overall_status":"UNKNOWN","enrollment_count":600,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT02898454","title":"Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":448,"lead_sponsor_name":"Sanofi","has_results":true},{"nct_id":"NCT04851964","title":"Efficacy and Safety of Tezepelumab in Participants With Severe Chronic Rhinosinusitis With Nasal Polyposis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":416,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT07424144","title":"An Extension Study to Investigate the Long-term Safety and Tolerability of Itepekimab in Adult Participants With Inadequately Controlled Chronic Rhinosinusitis With Nasal Polyps","phase":"PHASE3","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":380,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT07200336","title":"Anti-IL-5 Therapy With Simple Polypectomy Versus Extended Endoscopic Sinus Surgery for CRSwNP","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":360,"lead_sponsor_name":"Eye & ENT Hospital of Fudan University","has_results":false},{"nct_id":"NCT04998604","title":"EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":360,"lead_sponsor_name":"Sanofi","has_results":true},{"nct_id":"NCT07125586","title":"Real-Time Diagnosis of Eosinophilic Nasal Polyps Using High-Sensitivity Spectroscopy","phase":"NA","overall_status":"RECRUITING","enrollment_count":353,"lead_sponsor_name":"The Affiliated Hospital of Qingdao University","has_results":false},{"nct_id":"NCT07290140","title":"Paclitaxel-Coated Balloon Treatment of Chronic Rhinosinusitis","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Airiver Medical, Inc.","has_results":false},{"nct_id":"NCT06013241","title":"A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":288,"lead_sponsor_name":"Insmed Incorporated","has_results":false},{"nct_id":"NCT02912468","title":"A Controlled Clinical Study of Dupilumab in Patients With Bilateral Nasal Polyps","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":276,"lead_sponsor_name":"Sanofi","has_results":true},{"nct_id":"NCT05248997","title":"Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for the Acute Treatment of Chronic Rhinosinusitis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":261,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT07520162","title":"A Study to Investigate NPS and Symptoms in Chinese Adult Participants With CRSwNP Initiating Treatment With Tezepelumab","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":230,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT05942222","title":"A Real-world, Head-to-head Comparison of Dupilumab Versus Mepolizumab in Danish Patients With Chronic Rhinosinusitis With Nasal Polyps","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":220,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT07420257","title":"A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of CM326 in Participants With Chronic Rhinosinusitis With Nasal Polyposis","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":212,"lead_sponsor_name":"CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT06834360","title":"A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":210,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT06834347","title":"A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":210,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT06118554","title":"3D Printing to Improve Nasal Irrigation Outcome","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Ohio State University","has_results":false},{"nct_id":"NCT07446738","title":"A Study to Investigate the Clinical Outcome and Quality of Life in Chinese Post-operative CRSwNP Patients","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":200,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT06258772","title":"Mepolizumab in the Treatment of Patients With Severe Uncontrolled CRSwNP: a Multicentric Real Life Observational Study","phase":"","overall_status":"UNKNOWN","enrollment_count":199,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT07498374","title":"Efficacy and Safety of Fully Resorbable Sinus Drug-eluting Stents in Patients With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps After Surgery: A Prospective, Randomized Controlled Trial","phase":"NA","overall_status":"RECRUITING","enrollment_count":192,"lead_sponsor_name":"Tang-Du Hospital","has_results":false},{"nct_id":"NCT06706817","title":"A Study to Investigate Changes in Symptoms in Adult Participants With Chronic Rhinosinusitis With Nasal Polyposis Initiating Treatment With Tezepelumab","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":180,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT05938972","title":"Real Life Study of Biologicals in Patients With Severe CRSwNP","phase":"","overall_status":"RECRUITING","enrollment_count":180,"lead_sponsor_name":"University Hospital, Ghent","has_results":false},{"nct_id":"NCT07313917","title":"A Study to Evaluate the Efficacy and Safety of LP-003 Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":150,"lead_sponsor_name":"Longbio Pharma","has_results":false},{"nct_id":"NCT05598424","title":"CST1 Predictive Model of Oral Glucocorticoid Therapy Sensitivity for Chronic Rhinosinusitis With Polyps","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Beijing Tongren Hospital","has_results":false},{"nct_id":"NCT05649813","title":"A Study in Male and Female Adult Participants With Chronic Rhinosinusitis With Nasal Polyps In the Greater Gulf Region","phase":"","overall_status":"COMPLETED","enrollment_count":148,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT06776042","title":"Upper Airway Inflammation and Olfaction: Mechanisms of Loss and Recovery","phase":"NA","overall_status":"RECRUITING","enrollment_count":140,"lead_sponsor_name":"Cliniques universitaires Saint-Luc- Université Catholique de Louvain","has_results":false},{"nct_id":"NCT05626257","title":"Regulatory Post-Marketing Surveillance of Xolair® for Chronic Rhinosinusitis With Nasal Polyps","phase":"","overall_status":"COMPLETED","enrollment_count":135,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT07187583","title":"Tapering of Biologics in Chronic Rhinosinusitis With Nasal Polyps","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":135,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT05931744","title":"The Role of Budesonide Intrapolyp Injection in the Management of Type 2 Chronic Rhinosinusitis","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Kafrelsheikh University","has_results":false},{"nct_id":"NCT07399665","title":"ReAl-woRld Evaluation of tEzepelumab for Chronic rhinoSinusitis With Nasal Polyps in Russia","phase":"","overall_status":"RECRUITING","enrollment_count":110,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT06737198","title":"Correlation of Preoperative Indices (serum Vit D, Calcium, Phosphorus, FAR, PLR, SII) on Intraoperative Bleeding in CRS","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Nanjing First Hospital, Nanjing Medical University","has_results":false},{"nct_id":"NCT07316959","title":"Efficacy of Long-Term Low Dose Macrolide Therapy in Preventing Early Recurrence of Nasal Polyps After Endoscopic Sinus Surgery","phase":"NA","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Fatima Jinnah Medical University","has_results":false},{"nct_id":"NCT07198607","title":"Pistacia Lentiscus Oil Nasal Drops for Preventing Recurrence of Chronic Rhinosinusitis","phase":"NA","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Liaquat University of Medical & Health Sciences","has_results":false},{"nct_id":"NCT03956862","title":"GB001 in Adult Participants With Chronic Rhinosinusitis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":97,"lead_sponsor_name":"GB001, Inc, a wholly owned subsidiary of Gossamer Bio, Inc.","has_results":true},{"nct_id":"NCT02743871","title":"Study Of PF-06817024 In Healthy Subjects, In Patients With Chronic Rhinosinusitis With Nasal Polyps And in Patients With Atopic Dermatitis","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":97,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT04823585","title":"Aggravated Airway Inflammation: Research on Biological Treatment (Mepolizumab)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":95,"lead_sponsor_name":"Helsinki University Central Hospital","has_results":true},{"nct_id":"NCT06801353","title":"A Cohort Study on Biomarkers to Predict the Efficacy of Biologics for Chronic Rhinosinusitis with Nasal Polyps","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":90,"lead_sponsor_name":"Beijing Tongren Hospital","has_results":false},{"nct_id":"NCT05642806","title":"Comparison of Immune Profiles in Chronic Rhinosinusitis Patients After Mepolizumab Treatment","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"St. Paul's Sinus Centre","has_results":false},{"nct_id":"NCT05553951","title":"Adherence in Global Airways","phase":"NA","overall_status":"UNKNOWN","enrollment_count":90,"lead_sponsor_name":"Christiane Haase","has_results":false},{"nct_id":"NCT06372678","title":"Study of CM326 in Participants With Chronic Rhinosinusitis With Nasal Polyposis","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":90,"lead_sponsor_name":"Keymed Biosciences Co.Ltd","has_results":false},{"nct_id":"NCT05598411","title":"CST1-Guided Oral Glucocorticoids Management for CRSwNP","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":90,"lead_sponsor_name":"Beijing Tongren Hospital","has_results":false},{"nct_id":"NCT05324137","title":"A Study of CM326 in Patients With Chronic Rhinosinusitis With Nasal Polyps","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":88,"lead_sponsor_name":"Keymed Biosciences Co.Ltd","has_results":false},{"nct_id":"NCT06850805","title":"Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":84,"lead_sponsor_name":"Optinose US Inc.","has_results":false},{"nct_id":"NCT06164704","title":"A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Participants With Chronic Rhinosinusitis With Nasal Polyps","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":81,"lead_sponsor_name":"Upstream Bio Inc.","has_results":false},{"nct_id":"NCT06398873","title":"Effect of Dupilumab on Nasal Epithelial Barrier Function in Patients With CRSwNP","phase":"","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Medical University of Vienna","has_results":false},{"nct_id":"NCT05843019","title":"Adherence in Global Airways - Steroid Intake and Effects on Chronic Rhinosinosinutis","phase":"","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Christiane Haase","has_results":false},{"nct_id":"NCT06454240","title":"A Proof-of-concept Study of Lunsekimig Compared With Placebo in Adults With Chronic Rhinosinusitis With Nasal Polyps","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":79,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT04678856","title":"Dupilumab in CRSsNP","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":71,"lead_sponsor_name":"Sanofi","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}